Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

EFSA’s conclusion on assessing IARC glyphosate report to be available in Novemberqrcode

Sep. 24, 2015

Favorites Print
Sep. 24, 2015
EFSA is assessing the findings of a report by the International Agency for Research on Cancer (IARC) which concludes that the herbicide glyphosate is probably carcinogenic to humans. 
The report  , which was published in July, is being considered as part of EFSA’s on-going peer review of the re-evaluation of glyphosate. The re-evaluation was carried out by the BfR, the German risk assessment body.
To have sufficient time to take account of the IARC monograph, EFSA requested an extension of its original deadline. The Authority is confident of meeting the new deadline and expects the conclusion to be published in November.
IARC, the cancer agency of the World Health Organization, says in its report that there is evidence of an association between exposure to glyphosate and development of cancers such as non-Hodgkin lymphoma and lung cancer.
In the EU, active substances used in plant protection products are evaluated or re-evaluated using a phased approach.
First, an initial draft risk assessment report is produced by a designated rapporteur Member State (RMS). In the case of glyphosate the RMS is Germany. The report is peer-reviewed by EFSA, which sends its conclusion to the European Commission. The Commission then decides whether or not to include the substance in the EU’s list of approved active substances. 
Source: EFSA


More from AgroNewsChange

Hot Topic More

Subscribe Comment


Subscribe Email: *
Mobile Number:  





Subscribe AgroNews Daily Alert to send news related to your mailbox